“Montana is set to become a proving ground for experimental medical treatments, thanks to a newly passed bill.
The bill, signed into law by Governor Greg Gianforte this week, will permit clinics and doctors to sell and provide nearly any experimental drug to potential patients, so long as it has undergone at least one Phase I clinical trial. Advocates argue that the law will allow Montana to be a hub for medical tourism, especially for potentially life-extending medicine.”
From Gizmodo.
“California-based delivery platform DoorDash has launched its own drone delivery business after securing regulatory approval to operate commercial drone services in the United States.
The company has received Federal Aviation Administration (FAA) Part 135 air carrier certification, allowing it to launch DoorDash Air, an in-house drone programme developed by its robotics division, DoorDash Labs. Alongside operating the service, DoorDash is also developing its own aircraft for local deliveries.
The approval makes DoorDash one of only a handful of drone operators in the US authorised to run commercial delivery services under its own certificate.”
From Zag Daily.
“Ecuador and Canada signed a free trade agreement on Friday, Ecuador's government said, adding the deal will allow 99.6% of its exportable goods to enter Canada duty-free once it takes effect.”
From Reuters.
US Food and Drug Administration | Health Systems
“The U.S. Food and Drug Administration today licensed Ezplaz Freeze Dried Plasma (FDP), making it the first freeze-dried plasma product licensed for use in the United States. Ezplaz is intended for transfusion in adult patients who need plasma and for whom other plasma products are not available…
Unlike conventional plasma products that must be stored frozen and thawed before use, Ezplaz can be stored at room temperature, is stable after exposure to temperature fluctuations and is rapidly reconstituted. It is packaged in a plastic bag rather than a glass bottle, reducing the risk of breakage during handling and transport. FDA expects that these features will make the use of Ezplaz compatible with austere environments, potentially including combat zones, remote areas, and disaster response settings.”
“Science Corporation, a startup developing novel brain-computer interfaces (BCI), won approval from Europe’s medical device regulator to begin selling a device that restores vision lost from age-related macular degeneration.
The company said the device, called PRIMA, also received a designation from the US Food and Drug Administration that is the first step toward an expedited regulatory review, which could see the device used to treat two rare kinds of blindness.”
From TechCrunch.
